News
Vasculitis in the News
An RSS (Really Simple Syndication) feed is a news aggregator that uses software to search the internet for content that contains specific keywords.This RSS feed contains articles related to all forms of vasculitis. The articles in this feed come from a variety of online sources and are not directly associated with the Vasculitis Foundation (VF). Inclusion of an article in this RSS feed does not imply endorsement of the content by the VF.
- Tph cells linked to inflammation and disease activity in GPA - ANCA Vasculitis News
- Rituximab-Associated Posterior Reversible Encephalopathy Syndrome in Severe Hydralazine-Induced Antineutrophil Cytoplasmic Antibody Vasculitis: An Unexpected Complication - Cureus
- Beyond Classification: An Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Case - Cureus
- Short-Term Clinical and Immunologic Outcomes Conditional on SVR12 in Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Treated With Direct-Acting Antivirals: A Systematic Review and Meta-Analysis - Cureus
- Amgen stands by vasculitis drug Tavneos after FDA wants it pulled - ANCA Vasculitis News
- 6 Reasons to Feel Hopeful About an ANCA-Associated Vasculitis Diagnosis - everydayhealth.com
- 5 Tips to Support ANCA-Associated Vasculitis Management - everydayhealth.com
- Medical Specialists to Include on Your ANCA Vasculitis Treatment Team - everydayhealth.com
- Large-Vessel Vasculitis With Autoimmune Myelodysplastic Syndrome: An Uncommon Case of Large-Vessel Vasculitis With Cytopenia That Is Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic Syndrome (VEXAS) Negative - Cureus
- Fulminant Rheumatoid Vasculitis With Digital Necrosis and Cutaneous Ulcerations: A Case Report - Cureus
- Preparing for hip replacement surgery with ANCA vasculitis - ANCA Vasculitis News
- An Atypical Pediatric Dermatologic Presentation Unmasking an Unexpected Systemic Diagnosis: A Diagnostic Challenge - The Cureus Journal of Medical Science
- Amgen baulks at FDA request to withdraw Tavneos - pharmaphorum
- Understanding ANCA Vasculitis: GPA, MPA, and EGPA Explained - Everyday Health
- FDA Wants Drug Pulled From Market, Citing Liver Risk. Company Says No - MedPage Today
In Partnership with
ANCA Vasculitis News, a Bionews brand, provides trusted information, news, and connections that help to empower the ANCA vasculitis community and foster a space where hope thrives.